| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $26.90 ▲ +1.50% | Yesterday | $26.33 ▼ -0.63% | Tomorrow's Neurogene Inc. Common Stock (NGNE) setup is anchored to $26.50 and targets $26.90 (+1.50%). The near-term read is upside; watch $27.30 / $25.71 because daily realized volatility is about 7.75%. |
Tomorrow's Neurogene Inc. Common Stock (NGNE) setup is anchored to $26.50 and targets $26.90 (+1.50%). The near-term read is upside; watch $27.30 / $25.71 because daily realized volatility is about 7.75%. | ||||
| Week | $27.74 ▲ +4.67% | Last Week | $25.98 ▼ -1.96% | The 7-day Neurogene Inc. Common Stock model moves from $25.98 to $27.74 (+4.67%). It gives upside momentum context for this stock, so breaks around $27.30 / $25.71 matter more than a single tick. |
The 7-day Neurogene Inc. Common Stock model moves from $25.98 to $27.74 (+4.67%). It gives upside momentum context for this stock, so breaks around $27.30 / $25.71 matter more than a single tick. | ||||
| Month | $29.14 ▲ +9.96% | Last Month | $25.39 ▼ -4.18% | The 1-month Neurogene Inc. Common Stock target is $29.14 (+9.96%), compared with the live reference near $26.50. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Neurogene Inc. Common Stock target is $29.14 (+9.96%), compared with the live reference near $26.50. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $31.24 ▲ +17.87% | Last Year | $24.51 ▼ -7.51% | The 1-year Neurogene Inc. Common Stock scenario points to $31.24 (+17.87%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Neurogene Inc. Common Stock scenario points to $31.24 (+17.87%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $36.15 ▲ +36.43% | 5 Years Ago | $22.45 ▼ -15.30% | The 5-year Neurogene Inc. Common Stock view is $36.15 (+36.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Neurogene Inc. Common Stock view is $36.15 (+36.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $26.50 | Mid |
| Daily Change | -4.47% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 67% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $26.50 | Daily Change | -4.47% |
| Market Cap | $413.82M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.